Fem-Dophilus

Probiotic for Women with 25+ Years of Research That Supports Benefits For Vaginal and Urinary Tract Health*

• Oral Probiotic for Natural Vaginal Health*
• Clinically-Documented Benefits
• 25+ Years of Research and Clinical Studies For Vaginal and Urinary Tract Health*
• More Than 20 Studies Demonstrating Safety and Efficacy*
• Patented Lactobacilli Strains: GR-1® and RC-14®
• Prevention Magazine: Top 10 Breakthrough 07

Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14® to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic bacterial survival to the lower intestine.

GR-1®/RC-14® and VAGINAL FLORA (also called microbiota)

In one of the randomized clinical trials, 75% of women in the GR-1®/RC-14® probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.

Martinez, et al. Can J Microbiol 2009;55:133-138